Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Osiris Therapeutics (OSIR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 235,495
  • Shares Outstanding, K 34,530
  • Annual Sales, $ 59,870 K
  • Annual Income, $ -1,790 K
  • 36-Month Beta 0.89
  • Price/Sales 3.00
  • Price/Cash Flow N/A
  • Price/Book 2.95
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 12/30/16
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.0900 +10.84%
on 06/29/17
7.1500 -5.59%
on 07/26/17
+0.5615 (+9.07%)
since 06/26/17
3-Month
4.6600 +44.85%
on 04/28/17
7.1500 -5.59%
on 07/26/17
+1.9000 (+39.18%)
since 04/26/17
52-Week
2.6700 +152.81%
on 03/15/17
7.3900 -8.66%
on 11/11/16
+1.7700 (+35.54%)
since 07/26/16

Most Recent Stories

More News
Shares of OSIR Up 70.5% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Osiris Therapeut (NASDAQ:OSIR) on March 23rd, 2017 at $4.00. In approximately 4 months, Osiris Therapeut has returned 70.50% as of today's recent price of $6.82.

OSIR : 6.7500 (-1.03%)
Osiris Therapeut Has Returned 71.3% Since SmarTrend Recommendation (OSIR)

SmarTrend identified an Uptrend for Osiris Therapeut (NASDAQ:OSIR) on March 23rd, 2017 at $4.00. In approximately 4 months, Osiris Therapeut has returned 71.25% as of today's recent price of $6.85.

OSIR : 6.7500 (-1.03%)
Osiris Therapeut Up 57.6% Since SmarTrend Uptrend Call (OSIR)

SmarTrend identified an Uptrend for Osiris Therapeut (NASDAQ:OSIR) on March 23rd, 2017 at $4.00. In approximately 3 months, Osiris Therapeut has returned 57.60% as of today's recent price of $6.30.

OSIR : 6.7500 (-1.03%)
Osiris Appoints Linda Palczuk to serve as its President & CEO

Osiris Therapeutics, Inc. (Pink Sheets:OSIR) is pleased to announce that its Board of Directors has appointed Ms. Linda Palczuk, age 55, to serve as President and CEO, effective July 10, 2017. She will...

OSIR : 6.7500 (-1.03%)
Cartilage Repair/Regeneration Market Analysis By Treatment Modality, Application, Treatment Type, Site And Segment Forecasts, 2014 - 2025

Research and Markets has announced the addition of the "Cartilage Repair/Regeneration Market Analysis By Treatment Modality, By Application, By Treatment Type, By Site And Segment Forecasts, 2014 - 2025"...

ANIK : 47.99 (-0.56%)
SNN : 34.56 (+0.52%)
SYK : 145.75 (-0.21%)
OSIR : 6.7500 (-1.03%)
VCEL : 3.40 (+1.49%)
Stem Cells Market 2016-2024 - Global Strategic Business Report 2017

Research and Markets has announced the addition of the "Stem Cells - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada,...

CUR : 2.47 (-12.10%)
KOOL : 3.62 (+0.56%)
CYTX : 0.46 (-3.16%)
OSIR : 6.7500 (-1.03%)
LZAGF : 241.5000 (+6.98%)
MESO : 7.15 (+0.99%)
RNUGF : 0.0200 (-37.50%)
TIG : 21.02 (-0.78%)
ISCO : 1.4500 (+18.85%)
OMED : 3.58 (-1.10%)
ATHX : 1.62 (-0.61%)
Osiris Therapeutics Up 47.8% Since SmarTrend Uptrend Call (OSIR)

SmarTrend identified an Uptrend for Osiris Therapeutics (NASDAQ:OSIR) on March 23rd, 2017 at $4.00. In approximately 3 months, Osiris Therapeutics has returned 47.75% as of today's recent price of $5.91....

OSIR : 6.7500 (-1.03%)
Osiris Therapeutics Up 50.0% Since SmarTrend Uptrend Call (OSIR)

SmarTrend identified an Uptrend for Osiris Therapeutics (NASDAQ:OSIR) on March 23rd, 2017 at $4.00. In approximately 2 months, Osiris Therapeutics has returned 50.00% as of today's recent price of $6.00....

OSIR : 6.7500 (-1.03%)
Osiris Appoints David White to its Board of Directors

Osiris Therapeutics, Inc. (Pink Sheets:OSIR) is pleased to announce that its Board of Directors, at a Board Meeting on May 30, 2017, appointed Mr. David White as a director, upon recommendation of the...

OSIR : 6.7500 (-1.03%)
Osiris Therapeutics Has Returned 43.5% Since SmarTrend Recommendation (OSIR)

SmarTrend identified an Uptrend for Osiris Therapeutics (NASDAQ:OSIR) on March 23rd, 2017 at $4.00. In approximately 2 months, Osiris Therapeutics has returned 43.50% as of today's recent price of $5.74....

OSIR : 6.7500 (-1.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Support & Resistance

2nd Resistance Point 7.3367
1st Resistance Point 7.0433
Last Price 6.7500
1st Support Level 6.5633
2nd Support Level 6.3767

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.